The GLP-1s are really intriguing for people who mostly struggle with loss-of-control eating, says Joanna Steinglass, director of research at the Eating Disorders Research Clinic at Columbia University
Melamed JR, et al
Microdosing GLP-1 for autoimmune conditions is an emerging area of interest, with some practitioners maintaining patients on very low doses primarily for anti-inflammatory benefits rather than weight management
A randomized controlled trial found that GLP-1 mimics, such as exenatide and liraglutide, had a significant weight loss effect on obese/overweight patients without diabetes (171)
Wei Z, pinfang K, jing Z, zhuoya Y, Shaohuan Q, Chao S
There are various side-effects both mild and serious to taking GLP-1 drugs, including nausea and dizziness to pancreatitis and medullary thyroid cancer